[1]
N. Sulashvili, “THE MANIFESTATION OF PHARMACOGENETIC AND CLINICAL PERSPECTIVES ON MEDICATION-ASSOCIATED EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS): A COMPREHENSIVE EVALUATION OF IMPLICATED AGENTS, RISK FACTORS, AND TREATMENT MANAGEMENTS STRATEGIES IN GENERAL”, GS, vol. 7, no. 3, pp. 180–216, Jul. 2025.